Endpoints News – The biopharma world is here

SIGN UP

top stories

BREAKING: Danaher strikes deal to buy booming next-gen manufacturer Aldevron for $9.6B

14 hours ago

UPDATED: CureVac blames variants as a closely-watched Covid vaccine goes down in flames, failing pivotal study with ...

Yesterday

Sid Mukherjee's Vor adds clinical manufacturing facility at existing Boston-area site, beefing up for a commercial ...

15 hours ago

Bristol Myers breaks the bank on Eisai's folate receptor ADC drug, laying out more than $3B+ for rights

4 hours ago

Latest

As spotlight trains on biopharma diversity, most companies kept their C-suites exactly the same in 2020 — report

5 hours ago

In an effort to safely deliver mRNA, Stanford University teams up with German biotech Evonik

10 hours ago

'No reason to slow down anything here': CureVac plans to march on with Covid-19 vaccine after pivotal failure

12 hours ago

Biden invests $3B into antiviral development for Covid-19

12 hours ago

As it awaits pivotal review of lead drug, FibroGen bolsters its early pipeline with licensing deal for galectin ...

12 hours ago

Don’t hold your breath waiting for FDA nominee; A priority review for another Bristol Myers partner

12 hours ago

see latest stream

People

UPDATED: The Kodak insider trading drama continues as CEO set for questioning in NY state probe

Yesterday

UPDATED: Ex-FDA commish Stephen Hahn joins Flagship, a venture group that spawned Covid-19 vaccine maker Moderna

3 days ago

‘You have to get up on the podium’: Incoming BIO chair Paul Hastings on diversity, drug pricing and working with ...

3 days ago

Financing

A replacement for reading glasses? An RA, Versant-backed startup thinks its eyedrops could solve farsightedness

15 hours ago

Rick Klausner's crew of T cell specialists wraps $425M IPO, hitting Nasdaq alongside Verve, Molecular Partners

17 hours ago

A UK biotech looks to bring alliance between GSK, J&J, AstraZeneca, and top universities stateside with its first ...

23 hours ago

Startups

Michel Sadelain puts his name and new cell engineering tech behind 'agnostic' CAR-T startup chasing epigenetic ...

Yesterday

A Medicxi-backed startup looks to tackle treatment-resistant blood cancers, and it's going after AML first

Last week

A gene therapy biotech is bursting onto the scene with 12 programs in tow. An ultra-rare neuro disease is up first

Last week

Deals

Chinese oncology specialist Zai Lab brokers a deal with MacroGenics for up to 4 bispecifics with a modest down ...

Yesterday

Amid sluggish sales and dueling lawsuits, Novartis bows out of Amgen partnership, slashes staff

Yesterday

Exscientia spends SoftBank's cash in bid to edge out AI rivals

2 days ago

All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.

SIGN UP NOW

Subscribe to Endpoints News

Premium storiesSee all

FDA’s Cavazzoni calls for adcomms to ‘get back to the substance’

3 days ago

As Covid-19 shifts the world's attention to biotech, Noubar Afeyan's Flagship builds $3.4B fund to fuel new ...

3 days ago

FDA plans new studies on accelerated approval disclosures in biopharma ads

Last week

FDA dips its toe into the world of patient-reported outcomes for cancer trials

Last week

Don't missSee all

Viral manufacturer Vibalogics plots out expansion at German site as US growth plans are underway

13 hours ago

Blueprint Medicines nabs 4th approval in bid toward profitability

16 hours ago

Days after controversy greeted Biogen's blockbuster Alzheimer's OK, the big biotech concedes a setback on the tau ...

Yesterday

New Alzheimer's drug approval fallout: Public Citizen seeks removal of FDA's Woodcock, Cavazzoni and Dunn

Yesterday

Endpoints Standouts

Legacies: 60 biopharma pioneers over 60 who helped birth a tech revolution in the making

5 weeks ago

The Endpoints 100 survey: CEOs changed the way biotechs operate during the pandemic. Things will never be the same ...

2 months ago

The CHIC interview: Stéphane Bancel on Moderna's overnight transformation, the new timeline on vaccine development ...

2 months ago

Publisher's note

The 20(+1) under 40: Inside the next generation of biotech leaders

2 months ago

Peer review See all

Jun

11

Intercept retools C-suite with a pair of newcomers; Charles Ryan moves past Alzheimer's flops with another CEO ...

Jun

4

Two months after inking a SPAC deal, Renovacor taps new CMO; CureVac reels in a new development chief from Merck KGaA

May

28

Recursion CSO heads west for mini-brain upstart; Novartis vet steps up to the plate as CFO for Andrew Hirsch at C4 ...

May

21

CFO transition on the horizon at BioNTech as Sierk Poetting concentrates on COO duties; Centessa rides a wave of new ...

May

14

As Codiak enters 'next phase of growth,' Jennifer Wheler steps into CMO role; Mark Timney lines up his second CEO ...

Manufacturing channel feed

13 hours ago

Covid-19 manufacturing roundup: As the US government bags another 100M doses of Moderna shot, the biotech is chipping in on UAE rollout

President Joe Biden's administration has ordered another round of shots.

READ MORE

In a move to boost its natural killer candidates, Senti Bio will build out its own San Francisco manufacturing ...

13 hours ago

Bayer flushes money into the Nordics with $303M down payment on new Finnish plant, expansion

3 days ago

latest in Manufacturing

Recall report: Another drugmaker is pulling its version of metformin off shelves after a carcinogen scare

3 days ago

As it expands its footprint, Moderna reaches deal to commercialize Covid-19 vaccine doses in Middle East

6 days ago

Covid-19 manufacturing roundup: BioNTech announces plans to produce mRNA vaccines in Africa; AstraZeneca deliveries from Thailand delayed

Last week

An API firm with a history of J&J funding scores a major loan to advance its portfolio

Last week

With its controversial aducanumab approval in hand, Biogen gears up for a quick US rollout

Last week

see latest stories

Pharma channel feed

16 hours ago

Medicaid commission to Congress: Increase rebates for accelerated approval drugs

As the FDA continues to approve more new drugs under its accelerated approval pathway, the non-partisan Medicaid and CHIP Payment and Access Commission (MACPAC) is telling Congress to ...

READ MORE

Mississippi sues Eli Lilly, Sanofi and Novo over insulin prices as interchangeable biosimilars may arrive soon

2 days ago

Top analyst maps a rocky road for Vertex — unless they adopt a $10B M&A campaign to save the pipeline

3 days ago

latest in Pharma

Bayer closing down San Francisco research hub as attention turns to Berkeley plan

13 hours ago

In next-gen BTK battle, AbbVie and J&J tout pivotal data backing Imbruvica as a combo treatment

3 days ago

Months after FDA rejection, Sanofi touts pivotal win for rare disease drug sutimlimab as it preps to refile

6 days ago

Senators lambast new Alzheimer’s drug’s price but give Janet Woodcock a free pass on the approval decision

Last week

A second adcomm member abandons his post in aftermath of controversial aducanumab decision

Last week

see latest stories

R&D channel feed

2 days ago

UPDATED: Sage's second chance at depression hits the PhIII primary, but questions remain over durability, side effects

Looking to make a comeback after a big Phase III flop, Sage Therapeutics revealed data they believe could change the entire depression treatment landscape, given the vast array of failures ...

READ MORE

Biogen signals a big PhIII failure as the lead gene therapy in their $800M Nightstar buyout goes down in flames

3 days ago

A UK biotech looks to upset the preclinical model for liver drug development, and now it's gearing up for the clinic

Yesterday

latest in R&D

In a first, Regeneron's antibody cocktail reduces deaths for a subgroup of hospitalized Covid-19 patients

Yesterday

AstraZeneca's Covid-19 antibody cocktail misses the mark in preventing symptoms post-exposure

2 days ago

Terns Pharmaceuticals touts safety data from an ex-Eli Lilly candidate in the hunt for NASH treatment

3 days ago

Vertex and CRISPR Therapeutics unveil more positive gene therapy data, but busulfan again casts a shadow over the field

6 days ago

UPDATED: Vertex strikes out on its latest big shot at a rare genetic disease. But they're going to keep on swinging

Last week

see latest stories

FDA+ channel feed

Yesterday

Opinion: CMS needs to do FDA’s job and limit the use of Biogen’s pricey new Alzheimer’s drug

Now that the FDA has approved Biogen's expensive new Alzheimer’s drug with little clinical benefit potential, but plenty of potential to speed the bankruptcy of the government's ...

READ MORE

75M vaccine doses wasted: FDA spells out Emergent facility deficiencies at length in new memo

3 days ago

Novartis sets the tone for the radiopharma push with a prized acquisition winning breakthrough therapy designation

16 hours ago

latest in FDA+

UPDATED: A snakebit biotech receives second CRL for reformulated pain med, potentially putting the kibosh on its chances

3 days ago

FDA authorizes about 10M J&J vaccine doses, trashes 60M more from troubled Emergent plant

6 days ago

An expensive watch, shell companies and fake invoices: How two Israeli traders tapped into a $100M global biotech insider trading ring

6 days ago

Harvard’s Aaron Kesselheim resigns from expert panel in wake of aducanumab OK, blasting FDA for ‘worst drug approval decision in recent U.S. history'

Last week

UPDATE: Will Biogen ever publish the trial results for its new Alzheimer’s drug?

Last week

see latest stories